Table 2 Demographic and clinical descriptions of infants included in the study. Infants born to SARS-CoV-2-infected pregnant participants and healthy controls were recruited at the University of Massachusetts Memorial Health from April 27 to June 10, 2020. Additional infants born to healthy controls were recruited nationwide prior to the COVID-19 pandemic
From: The microbiota of pregnant women with SARS-CoV-2 and their infants
Demographics and clinical variables | Infants born to SARS-CoV-2-positive pregnant women (N = 47) | Infants born to healthy controls pregnant women (N = 21) | Total (N = 68) | P valuea |
|---|---|---|---|---|
Gender | Â | Â | Â | 0.282 |
 Female, N (%) | 29 (61.7%) | 10 (47.6%) | 39 (57.4%) |  |
Infant weight (g) | Â | Â | Â | 0.518 |
 Mean (SD) | 3200 (638) | 3420 (444) | 3270 (590) |  |
Delivery mode | Â | Â | Â | 0.909 |
 Vaginal, N (%) | 32 (68.1%) | 14 (66.7%) | 46 (67.6%) |  |
NICU admission, N (%) | 8 (17.0%) | 2 (9.5%) | 10 (14.7%) | 0.423 |